MedPath

Effect of Persiyawashan in Polycystic Ovarian Syndrome

Phase 2
Conditions
Health Condition 1: N839- Noninflammatory disorder of ovary,fallopian tube and broad ligament, unspecified
Registration Number
CTRI/2024/06/069385
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Both unmarried and married female patients between 18-42 year of age.

Fulfilling Rotterdam’s criteria (clinical hyperandrogenism or biochemical

hyperandrogenism, evidence of oligo-amenorrhea, polycystic appearing-ovarian

morphology on ultrasound)

Exclusion Criteria

Patients with systemic Hypertension, Diabetes mellitus and endocrine diseases like thyroid dysfunction and hepatic disorders.

Pregnant and lactating women.

Patient on hormonal contraceptives (use within 3 months).

Patients with history of malignancies, endometrial tuberculosis, uterine fibroid more than 3 centimeter,

other ovarian cyst more than 2 centimeters

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath